Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

5.4K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.4K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

4.9K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
4.9K
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

6.0K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
6.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.3K
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.

European journal of nuclear medicine and molecular imaging·2021
Same author

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

European journal of nuclear medicine and molecular imaging·2021
Same author

Clinical validity of increased cortical uptake of [<sup>18</sup>F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework.

European journal of nuclear medicine and molecular imaging·2021
Same author

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.

Molecular neurodegeneration·2020
Same author

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

Molecular psychiatry·2017
Same author

A comparison of the regional ontogenesis of nicotine- and muscarine-like binding sites in mouse brain.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014

Related Experiment Video

Updated: Apr 28, 2026

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

19.3K

Regional [(3)H]acetylcholine and [(3)H]nicotine binding in developing mouse brain.

C Larsson1, A Nordberg, Y Falkeborn2

  • 1Department of Pharmacology, Uppsala University, Uppsala, Sweden.

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|May 31, 2014
PubMed
Summary

This study tracked nicotine-like binding sites in developing mouse brains using [(3)H]acetylcholine and [(3)H]nicotine. Nicotine binding sites increased with age, while acetylcholine binding showed region-specific developmental patterns.

More Related Videos

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
10:48

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

Published on: January 25, 2019

10.6K
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

12.9K

Related Experiment Videos

Last Updated: Apr 28, 2026

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

19.3K
Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
10:48

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

Published on: January 25, 2019

10.6K
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

12.9K

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Nicotinic acetylcholine receptors (nAChRs) are crucial for brain development and function.
  • Understanding the developmental trajectory of these receptors is essential for comprehending neurological processes.

Purpose of the Study:

  • To investigate the postnatal development of nicotine-like binding sites in different mouse brain regions.
  • To compare the developmental patterns of binding sites detected by [(3)H]acetylcholine and [(3)H]nicotine.

Main Methods:

  • In vitro binding assays were performed on brain tissues from mice at various postnatal ages (3, 7, 12, 17, and 30 days).
  • Two radioligands, [(3)H]acetylcholine ([(3)H]ACh) and [(3)H]nicotine ([(3)H]NIC), were used to quantify binding sites.

Main Results:

  • [(3)H]NIC binding sites showed a gradual increase with age across all studied brain regions (cortex, hippocampus, midbrain, cerebellum).
  • [(3)H]ACh binding exhibited a distinct peak on postnatal day 12 in the cerebellum and midbrain.
  • [(3)H]ACh binding remained relatively stable in the hippocampus and cortex, with a minor transient increase in the cortex on day 7.

Conclusions:

  • The developmental patterns of nicotine-like binding sites differ depending on the radioligand used.
  • [(3)H]ACh binding site development parallels that of [(3)H]alpha-bungarotoxin sites, suggesting distinct receptor populations.
  • [(3)H]NIC binding reflects a broader developmental increase in certain nicotinic sites.